Breast Cancer

Latest News

Supplemental breast cancer screenings criteria leaves Black women ineligible despite high percentage of false-negative mammograms. | Image Credit: breastcancerscreening-H_Ko.jpeg
Supplemental Breast Cancer Screening Law Renders Many High-Risk Black Women Ineligible

August 5th 2025

The Pennsylvania Act 1 of 2023 eligibility criteria for supplemental screenings based on breast density and lifetime risk of breast cancer disproportionately disqualify Black women from supplemental screenings despite their high risk of aggressive cancer and persistent history of false-negative mammograms.

Black women are at a higher risk for breast cancer mortality due to social determinants of health and lack of inclusivity in breast cancer genome research. | Image credit: Stafeeva - stock.adobe.com.jpeg
Social Disparities Increase Breast Cancer Mortality for Black Women

July 27th 2025

Early-onset breast cancer found to be associated with certain hormone therapy usage in younger women. | Image Credit: Chinnapong - stock.adobe.com
Hormone Therapy Use May Impact Early-Onset Breast Cancer Risk

July 26th 2025

Menopausal hormone therapy is associated with a higher risk of developing certain breast cancer subtypes. | Image Credit: vectorfusionart - stock.adobe.com
Hormone Therapy Use Differentially Associated With Breast Cancer Subtypes

July 16th 2025

In women who have overweight or obesity in adulthood, the risk of breast cancer is 1.15 times higher among those who also have a history of CVD. | Image credit: Axel Kock - stock.adobe.com
CVD and BMI Linked to Postmenopausal Breast Cancer

July 14th 2025

Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

Experts discuss the impact of CDK4/G inhibitor use, including medication cost, total care costs, toxicity profiles, and strategies to manage and optimize patient outcomes in high-risk early breast cancer.

Watch the latest AJMC Peer Exchange on Advances in CDK4/6 Inhibitor Use in High-Risk Early Breast Cancer: 2024 Updates

More News

Gut Microbiota May Influence pCR in Early-Stage Breast Cancer
September 17th 2020

Gut Microbiota May Influence pCR in Early-Stage Breast Cancer

Maggie L. Shaw
A study out of Scotland has linked levels of 2 short-chain fatty acids in female patients with early-stage breast cancer to pathological complete response (pCR) to neoadjuvant chemotherapy.
Hormone Exposure, Early Puberty May Increase Breast Cancer Risk for Adolescent Girls
September 14th 2020

Hormone Exposure, Early Puberty May Increase Breast Cancer Risk for Adolescent Girls

Maggie L. Shaw
Long-term study results show which mechanisms of early-onset puberty in adolescent girls may predispose them to a greater risk of developing breast cancer.
Possible Link Found Between Breast Cancer Mortality and Childhood Radiation Treatment
September 11th 2020

Possible Link Found Between Breast Cancer Mortality and Childhood Radiation Treatment

Maggie L. Shaw
Study results show that among premenopausal women, adulthood second primary breast cancer may carry with it a 2-fold greater risk of death if they had undergone radiation treatment for cancer as a child or young adult.
Early-Onset Breast Cancer Possibly Linked to Preeclamptic Pregnancy, High Birth Weight
September 6th 2020

Early-Onset Breast Cancer Possibly Linked to Preeclamptic Pregnancy, High Birth Weight

Maggie L. Shaw
With little research on the subject, the investigators sought out a connection between certain perinatal factors and risk of young-onset breast cancer in a sister-matched case-control study.
Outcomes and Future of Clinical Pathways
September 2nd 2020

Outcomes and Future of Clinical Pathways

Adding Multiple in a Class and Measuring Success of Pathways
September 2nd 2020

Adding Multiple in a Class and Measuring Success of Pathways

Development of Clinical Pathways and Patient Characteristics
September 2nd 2020

Development of Clinical Pathways and Patient Characteristics

Adjuvant CDK4/6 Inhibition: When it Will Become Routine
September 2nd 2020

Adjuvant CDK4/6 Inhibition: When it Will Become Routine

Breast Cancer Treatment: How COVID-19 Has Altered Care
September 2nd 2020

Breast Cancer Treatment: How COVID-19 Has Altered Care

The Impact of Patient Preference on Payer Compliance
September 2nd 2020

The Impact of Patient Preference on Payer Compliance

Payer Approval for Frontline Options: Restrictive or Broad?
September 2nd 2020

Payer Approval for Frontline Options: Restrictive or Broad?

Breast Cancer Pathway Guidelines for Practitioners
September 2nd 2020

Breast Cancer Pathway Guidelines for Practitioners

Defining Episode of Care in Metastatic Disease
September 2nd 2020

Defining Episode of Care in Metastatic Disease

Breast Cancer Management: Global Cost of Care
September 2nd 2020

Breast Cancer Management: Global Cost of Care

Formulary Consideration and Clinical Impact of Cost
September 2nd 2020

Formulary Consideration and Clinical Impact of Cost

Distinguishing Among the Available CDK4/6 Inhibitors
September 2nd 2020

Distinguishing Among the Available CDK4/6 Inhibitors

Role of CDK4/6 Inhibitors and Patient Selection
September 2nd 2020

Role of CDK4/6 Inhibitors and Patient Selection

Pivotal Studies for CDK4/6 Inhibitors
September 2nd 2020

Pivotal Studies for CDK4/6 Inhibitors

First-line Therapy for HR-Positive, HER2-Negative mBC
September 2nd 2020

First-line Therapy for HR-Positive, HER2-Negative mBC

Value-Based Care vs Cost of Treatment for mBC
September 2nd 2020

Value-Based Care vs Cost of Treatment for mBC

Provider Responsibility to Cost Burden for mBC Therapy
September 2nd 2020

Provider Responsibility to Cost Burden for mBC Therapy

Patient Cost Burden for Metastatic Breast Cancer Therapy
September 2nd 2020

Patient Cost Burden for Metastatic Breast Cancer Therapy

Provider Perspective on Value-Based Care for mBC
September 2nd 2020

Provider Perspective on Value-Based Care for mBC

Patient, Advocate, and Payer on Value-Based Care for mBC
September 2nd 2020

Patient, Advocate, and Payer on Value-Based Care for mBC

Patient Journey and Development of Metastatic Breast Cancer
September 2nd 2020

Patient Journey and Development of Metastatic Breast Cancer

Age a Leading Factor in COVID-19–Related Breast Cancer Treatment Delays
August 31st 2020

Age a Leading Factor in COVID-19–Related Breast Cancer Treatment Delays

Maggie L. Shaw
Questionnaire results from the first weeks of the coronavirus disease 2019 (COVID-19) pandemic show that breast cancer treatment delays happened more often for younger vs older women.
Being Each Other’s Hero: Facing MBC Together
August 25th 2020

Being Each Other’s Hero: Facing MBC Together

Maggie L. Shaw
At diagnosis, approximately 6% of breast cancers are metastatic breast cancer (MBC), which although treatable is not curable. Experts predicted that 276,480 women and 2620 men would receive such a diagnosis in 2020.
Anti-inflammatory Diet May Help Postmenopausal Breast Cancer Survival
August 23rd 2020

Anti-inflammatory Diet May Help Postmenopausal Breast Cancer Survival

Maggie L. Shaw
Risks of all-cause mortality and breast cancer-specific mortality decreased when female patients followed a more anti-inflammatory diet after their diagnosis of postmenopausal invasive breast cancer.
Study Shows Paclitaxel, Carboplatin Effective Against Triple-Negative Breast Cancer
August 18th 2020

Study Shows Paclitaxel, Carboplatin Effective Against Triple-Negative Breast Cancer

Maggie L. Shaw
The Adjuvant Platinum and Taxane in Triple-Negative Breast Cancer trial investigated this combination adjuvant treatment vs the standard-of-care anthracycline plus docetaxel among patients with operable disease.
center for biosimilars
August 17th 2020

Choice Is Vital to Biosimilar Savings Picture, Panelists Say

Tony Hagen
The challenges of complying with payer mandates in biosimilars were discussed in a webinar sponsored by The American Journal of Managed Care® and The Center for Biosimilars®.
<1
...
5678910111213>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo